Display Settings:

Format

Send to:

Choose Destination
    Genet Med. 2004 Jul-Aug;6(4):204-10.

    Genetic testing for alpha1-antitrypsin deficiency.

    Source

    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, 812 CSB, Charleston, SC 29425, USA.

    Abstract

    PURPOSE:

    The Alpha Coded Testing Study investigated the risks, benefits, and psychological impact of home genetic testing for alpha1-antitrypsin deficiency.

    METHODS:

    In the study, 996 adult individuals requested and returned a home-administered, confidential, fingerstick blood test.

    RESULTS:

    Individuals highly rated the benefits of establishing a diagnosis (82%), helping family members (86%), and anticipating peace of mind (79%). 78% of 239 current smokers reported a high likelihood of smoking cessation if diagnosed with AATD. After testing, more than 60% indicated that they would share the results with family and physicians but < 30% would share results with insurance companies.

    CONCLUSIONS:

    Confidential home testing for genetic disorders requires a comprehensive program of participant support.

    PMID:
    15266208
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk